Srijan Kumar is an Assistant Professor in the School of Computational Science and Engineering at Georgia Institute of Technology's College of Computing. His research focuses on data science, AI for security, and online safety, addressing challenges in detecting malicious users, misinformation, and enhancing AI robustness. His work has been deployed in platforms like Flipkart and Wikipedia, and recognized through awards such as the NSF CAREER and Forbes 30 Under 30. Education: B.Tech from Indian Institute of Technology, Kharagpur Ph.D. in Computer Science from University of Maryland, College Park Postdoctoral training at Stanford University Research Interests: Multi-modal/multi-lingual detection of harmful content and users Adversarial robustness of AI models Graph and network analysis for early detection Responsible recommender systems Awards & Grants: NSF CAREER Award (2023) Kavli Fellow (2022) Facebook/Adobe Faculty Awards NSF Convergence Accelerator Phase II grant ($5M) Advising & Labs: Leads the CLAWS Lab, advising over 20 students. Active in mentoring through conferences and NSF-funded projects.
Vadim Cherezov, the Ester Dornsife Chair in Biological Sciences and Professor at the University of Southern California (USC), leads groundbreaking research in membrane protein structure and function. Affiliated with the Bridge Institute, Department of Chemistry, and Michelson Center for Convergent Bioscience, his work focuses on GPCRs, ion channels, and transporters—critical targets for drug discovery. His team leverages advanced techniques like Lipidic Cubic Phase (LCP) and Serial Femtosecond Crystallography (SFX) at XFEL facilities to solve high-resolution structures under physiological conditions. Institutional Affiliations: Bridge Institute, USC Michelson Center, Department of Chemistry, Department of Pharmacology and Pharmaceutical Sciences. Key Collaborations: Katritch Lab, Kuhn Lab, NIH, European XFEL. His research explores the role of lipids in modulating GPCR function, addressing diseases like Alzheimer’s, diabetes, and cancer. By solving the structure of the A 2A adenosine receptor via sulfur SAD phasing at XFEL, Cherezov’s lab demonstrated de novo phasing without heavy atoms. This breakthrough enables structural studies of previously intractable membrane proteins. Scientific Awards & Grants: NIH R01 GM108635, U54 GM094618, U54 GM094599, R01 GM095583 Science Signaling Breakthroughs of the Year (2014) Cherezov mentors a dynamic team, including postdocs (e.g., Dong-Gyun Kim), graduate students (e.g., Behnaz Davoudinasab), and alumni (e.g., Benjamin Stauch at Eli Lilly, Nairie Michaelian at Genentech). His lab’s publications span Nature , Science , and Cell , with recent work on Science Advances (2025) addressing ABEL-FRET for GPCR dynamics.
Jered Haun is an Associate Professor at the Samueli School of Engineering , University of California, Irvine , with joint appointments in Biomedical Engineering , Chemical and Biomolecular Engineering , and Materials Science and Engineering . Based in 3107 Natural Sciences II , his research focuses on developing nanoengineering and molecular medicine technologies to improve disease diagnosis and treatment. Email: jered.haun@uci.edu Phone: (949) 824-1243 Research Interests include: Nanomaterial Probes for molecular profiling and disease detection Microfabricated Platforms for cell analysis and tissue processing Targeted Delivery Carriers that interact with unique disease molecules Technologies employed in his lab encompass: Fluorescence imaging and MRI enhancements Bioorthogonal chemistry and nanosensor development Micro-NMR for tumor analysis Quantum dot-based detection systems Awards include: NIH National Cancer Institute's Innovative Molecular Analysis Technologies Funding The Haun Laboratory actively recruits graduate and undergraduate students for projects related to nanoengineering, molecular medicine, and microfluidic device development.
Amanda Stockton is an Associate Professor at the School of Chemistry and Biochemistry, Georgia Institute of Technology. Her research focuses on the development of analytical instruments for planetary exploration and the study of terrestrial analog environments to understand conditions suitable for life emergence. She leads the Stockton Lab, which specializes in microfluidics, biosignature detection, and astrobiological applications. Education: B.S. in Chemistry and Aerospace Engineering, Massachusetts Institute of Technology (2004) M.A. in Chemistry, Brown University (2006) Ph.D. in Chemistry, University of California Berkeley (2010) Stockton’s work bridges planetary science and analytical chemistry, targeting extraterrestrial life detection through technologies like the FELDSPAR and IMPOA projects. Her research explores sea spray aerosols, icy moon penetrators, and microfluidic systems for environmental and medical diagnostics. Research Highlights: Instrument development for Europa and Enceladus missions Microfluidic tools for origin-of-life experiments Terrestrial applications in environmental monitoring and point-of-care diagnostics Collaborative studies in Icelandic and Antarctic analog environments The Stockton Lab’s publications reveal expertise in biosignature preservation, Raman spectroscopy, and planetary habitability, with a focus on Mars and ocean worlds. Her team has pioneered low-cost microfluidic platforms like GLUE and modular CE-LIF systems.
Anja Boisen is a Professor and Head of the Drug Delivery and Sensing Section at the Department of Health Technology, Technical University of Denmark (DTU). Her research focuses on advanced drug delivery systems, sensing technologies, and nanotechnology applications in biomedical engineering. She leads a multidisciplinary team developing innovative devices such as microcontainers, microneedles, and lab-on-a-disc platforms for targeted drug delivery and diagnostics. Her work contributes to UN Sustainable Development Goals, particularly in improving health and reducing inequalities. Key research areas include surface-enhanced Raman spectroscopy (SERS), microfabrication for medical devices, and biomaterials for tissue engineering. She has supervised multiple PhD students, including projects on oral drug delivery systems, gastrointestinal retention devices, and energy-harvesting materials for biomedical applications. Boisen’s team has pioneered technologies like self-unfolding foils for oral delivery and smart drug delivery microparticles. Their innovations aim to enhance therapeutic efficacy while minimizing side effects. She has been recognized with the Sensor Division Outstanding Achievement Award (2022) for her contributions to sensor technology. Her lab actively collaborates internationally, advancing applications in cancer therapy, antibiotic monitoring, and gut microbiota research. Current projects explore high-throughput 3D tumor modeling, SERS-based diagnostics, and biodegradable materials for bone fixation.
David Juncker is a Professor and Department Chair of the Department of Biomedical Engineering at McGill University. He serves as a Principal Investigator at the McGill University & Genome Quebec Innovation Centre and holds associate memberships in the Department of Neurology and Neurosurgery, Department of Electrical and Computer Engineering, Division of Experimental Medicine, Department of Surgery, and Goodman Cancer Research Centre. His research focuses on micro- and nano-bioengineering technologies for bioanalysis, precision medicine, and organs-on-chips. Key areas include microfluidics, lab-on-a-chip devices, biomedical sensors, medical diagnostics, biomaterials, tissue engineering, and cancer biomarker discovery. His lab develops scalable antibody microarrays, self-powered diagnostic platforms, microfluidic probes for brain tissue perfusion, and nanogradients for neuronal navigation, with applications in cancer diagnostics, global health, and neuroscience. Recent publications (2023-2025) reveal strong emphasis on extracellular vesicle analysis, single-cell proteomics, 3D-printed microfluidic/organ-on-a-chip systems, and capillary-driven circuits. Key trends include low-cost point-of-care diagnostics, advanced circulating tumor cell isolation methods, and biomimetic synthetic vesicles for drug delivery, demonstrating translational potential in early disease detection. Dr. Juncker leads a highly interdisciplinary team comprising undergraduate and graduate students, post-doctoral fellows, and staff from diverse scientific, engineering, and cultural backgrounds. His lab actively recruits Canadian/permanent resident graduate students for projects on single extracellular vesicle and protein detection in cancer and infectious diseases, leveraging microfluidics and wearables for biomarker discovery. The Juncker Lab operates from the McGill University & Genome Quebec Innovation Centre (740 Dr. Penfield Avenue, Room 6206). It maintains a collaborative, multicultural environment focused on developing transformative micro- and nano-bioengineering technologies with significant potential impact on human health diagnostics and treatment.
Ueli Grossniklaus is an Ordinary Professor at the University of Zurich within the Faculty of Mathematical and Natural Sciences , affiliated with the Department of Plant and Microbiology . His work focuses on plant developmental biology, particularly epigenetic and genetic mechanisms governing reproduction and adaptation. Key Courses: Epigenetics, Plant Biology Workshop, Group Seminars on Current Research Laboratory Techniques: Advanced methods in plant cell mechanics, transcriptomics, and genome editing Research Interests span plant epigenetics, reproductive biology, and the interplay between environmental stress and genetic regulation. He investigates: Mechanistic control of gametogenesis and fertilization Epigenetic contributions to plant adaptation Evolutionary implications of asexual reproduction Biophysical forces in plant cell growth Publication Trends (2025–2018) reveal expertise in: Arabidopsis and fern model systems Epigenetic regulation (DNA methylation, histone dynamics) Apomixis and hybrid seed failure mechanisms Biomechanics of pollen tubes and carnivorous plants Genome editing tools (CRISPR) and long-read sequencing Scientific Collaborations include interdisciplinary projects on: Microfluidic devices for plant cell analysis Gene drive ecology and ethics 3D imaging of plant reproductive structures Advising and Grants focus on mentoring through research internships in developmental biology, genetics, and systems biology. His lab engages in: Epigenetic response to environmental stress Cell wall mechanics in reproduction Computational modeling of plant growth Laboratory Teams integrate plant biologists, bioengineers, and computational scientists to study: Mechanistic gene regulation Evolutionary developmental biology Microrobotics for cellular force measurement
Shabaz Mohammed is an Associate Professor of Proteomics at the University of Oxford, holding joint appointments in the Departments of Chemistry and Biochemistry. Since 2020, he has served as Head of the Mechanistic Proteomics research programme at the Rosalind Franklin Institute. His research focuses on advancing proteomics technologies to study protein post-translational modifications and their roles in cellular processes, with applications in viral infections and disease mechanisms. Education: BSc in Chemistry, UMIST (now The University of Manchester), 1999 PhD in Biological Mass Spectrometry, University of Manchester, 2003 Postdoctoral Research, University of Southern Denmark (with Ole Jensen), 2005-2008 Postdoctoral Research, Utrecht University (with Albert Heck), 2008 Professor Mohammed's research centers on developing novel mass spectrometry approaches for large-scale characterization of protein post-translational modifications (PTMs). His group innovates in chromatographic techniques for single-cell proteomics, creates materials for PTM enrichment (glycosylation/phosphorylation), and applies these tools to study viral infections (SARS-CoV-2), cell cycle regulation, and signaling pathways. His work bridges chemistry, biochemistry, and cell biology to understand dynamic protein functions in health and disease. His recent publications (2023-2025) demonstrate strong emphasis on viral proteomics, particularly virus-host RNA-binding protein interactions, and innovations in mass spectrometry fragmentation techniques and chromatography. Key themes include viral remodeling of host cells, new labeling strategies for PTMs, and advancements in single-cell proteomics, with significant implications for understanding viral pathogenesis. Scientific Awards: No specific awards or fellowships were detailed in the source material. Advising and Grants: Information regarding graduate students supervised or specific research grants was not provided in the available text. As an active research group leader, Professor Mohammed likely mentors PhD students and secures competitive funding for proteomics research. Laboratories and Collaborations: Professor Mohammed leads a research group at Oxford focused on proteomics technology development. He collaborates extensively with the Ben Davis group on PTM detection materials and across the university on biochemical applications. At the Rosalind Franklin Institute, he heads the Mechanistic Proteomics programme to unravel protein functions through advanced proteomic methods.
Prof. Kwang W. Oh is a tenured Professor at the Department of Electrical Engineering and Department of Biomedical Engineering within the School of Engineering and Applied Sciences at University at Buffalo (SUNY at Buffalo) . He serves as the Director of Graduate Studies in Electrical Engineering and Director of SMALL (Sensors and MicroActuators Learning Lab) . His academic journey includes PhD and MS in Electrical and Computer Engineering from University of Cincinnati (2001, 1997) and BS in Physics from Chonbuk National University (1995). Prof. Oh's research expertise lies at the intersection of microfluidics , BioMEMS , and lab-on-a-chip technologies. His lab has pioneered vacuum-driven microfluidic devices , PDMS-based systems , droplet manipulation , and chemical-free fabrication techniques . His work enables point-of-care diagnostics , single cell analysis , and wearable medical sensors , with significant contributions to sample-to-answer nanosystems and world-to-chip interfacing . The scientific awards section highlights his excellence in teaching and research: SUNY Chancellor's Award for Excellence in Teaching (2020) Meyerson Award for Undergraduate Teaching (2019) Qualcomm Faculty Award (2019) Senior Teacher of the Year (2017) Royal Society of Chemistry's Emerging Investigators (2013) Samsung Electronics' CEO Honor (2003) His lab has produced numerous PhD and MS students including Dr. Anyang Wang (2020), Dr. Nikhila Nyayapathi (2020), Mr. Liam Christie (2021), and Dr. Domin Koh (2019). As a conference chair , he has organized symposia at NanoTech (2012-2026) and served as editorial board member for Sensors , Micromachines , and Biomedical Engineering Letters .
Tsun-Ming Tseng is a Professor and principal investigator at the Chair of Electronic Design Automation at the Technical University of Munich (TUM). He leads the Emerging Technology Group and oversees multiple DFG/BMBF-funded research projects in the areas of microfluidic large-scale integration, optical network-on-chip design, and novel microfabrication techniques. Dr. Tseng's research focuses on design automation for emerging technologies, with particular expertise in three main areas: microfluidic large-scale integration, optical network-on-chip systems, and novel microfabrication processes. His work bridges the gap between electronic design automation and cutting-edge applications in bioengineering, photonics, and advanced manufacturing. His research group develops sophisticated algorithms and tools for optimizing design, reliability, and performance in these emerging domains. Analysis of Dr. Tseng's recent publications reveals a strong focus on practical implementation challenges in emerging technologies. His work spans both theoretical algorithm development and practical system implementation, with particular emphasis on reliability, performance optimization, and manufacturing considerations. The research shows increasing integration between different technology domains, particularly the convergence of microfluidics, optical networking, and electronic design automation. Dr. Tseng has been awarded multiple significant research grants including: "DE-TW-CloudWRONoC" (BMBF-NSTC project, PI, 2025-2028, EUR 797.7K) "DE-TW-PI3D" (BMBF-NSTC project, PI, 2024-2027, EUR 391.6K) "Physical Design for Microfluidic Large-Scale Integration" (DFG research grant, PI, 2024-2026, EUR 331.9K) Multiple other DFG and industrial projects totaling over EUR 3 million in funding He has successfully supervised numerous doctoral researchers and postdoctoral fellows, with current group members including Jiahui Peng, Debraj Kundu, Liaoyuan Cheng, and several others. Dr. Tseng leads the Emerging Technology Group at TUM, which focuses on developing design automation methodologies for next-generation technologies. The group maintains strong collaborations with international institutions, including partnerships with researchers in Taiwan and Hong Kong. The team operates state-of-the-art facilities for research in microfluidics, optical networking, and advanced microfabrication techniques.
Dr. Jing Fu is an Associate Professor in the Department of Mechanical & Aerospace Engineering at Monash University. He holds a PhD in nano/microfabrication processes for biomedical applications from Pennsylvania State University (2008). His research focuses on nanoengineering tools, particularly Focused Ion Beam (FIB) technology for imaging and manipulating single cells. He is a principle scientist in collaborative projects with CSIRO MCN and Australian Synchrotron, exploring nanomaterial dynamics in immune cells. His expertise spans FIB/SEM/TEM, cryogenic environments, and multidisciplinary biomedical engineering. Education: M.Eng/Ph.D., Pennsylvania State University, USA (2008). Postdoctoral Fellowship at NIH (2008–2010). Joined Monash Faculty of Engineering in 2010. Research Interests: 3D visualization of HIV viral entry, compositional mapping of mammalian cells, and FIB-driven correlative imaging. Projects include '3D Cryo-FIBSEM Imaging Facility' (2015–2017) and 'Targeting NDM-producing superbugs' (2013–2015). Current collaborations involve tooth enamel evolution studies (2025–2028). Key Contributions: Over 90 publications, including work on graphene encapsulation for APT, ion beam fabrication of nanostructures, and polymyxin antibiotic efficacy. His research aligns with UN SDGs for health and innovation. Grants & Awards: ARC and NHMRC funding for projects on superbug targeting and imaging facilities. Active in multidisciplinary teams addressing biomedical challenges.
Dr. Angelika Niemz is the Finnigan Professor of Applied Life Sciences and Dean of the Riggs School of Applied Life Sciences at Keck Graduate Institute. She holds a PhD in Chemistry from the University of Massachusetts Amherst (1999) and a bachelor's degree from the University of Konstanz, Germany (1992). Her expertise spans medical diagnostics, nucleic acid testing, and infectious disease research. Dr. Niemz has held progressive roles including Assistant Professor (2002), Associate Professor (2008), Director of Research (post-sabbatical 2009), Department Chair (2021), and Associate Dean (2022). Her research focuses on developing point-of-care diagnostic systems for infectious diseases like tuberculosis, Chlamydia, and Dengue fever, integrating isothermal amplification and lateral flow detection technologies. She has secured funding from NIH, NSF, and DoD, and organized a summer undergraduate research program at KGI. Research Interests: Dr. Niemz specializes in translating molecular diagnostics into practical tools for global health challenges. Her work emphasizes low-cost, rapid nucleic acid testing systems for resource-limited settings, including innovations in sample preparation, isothermal amplification methods, and Raman-based sensor technologies for volatile biomarkers. Her team has developed integrated sample-to-answer platforms for tuberculosis diagnosis and mechanical bacterial lysis devices for robust pathogen detection. Advising & Grants: Dr. Niemz has directed externally funded research projects totaling over $X million, managed multidisciplinary teams, and mentored numerous graduate students in bioengineering and applied life sciences. Her administrative leadership includes overseeing faculty development as Associate Dean and advancing interdisciplinary programs at KGI. Current initiatives focus on expanding point-of-care technologies and fostering industry partnerships in diagnostic innovation. Labs & Teams: Her laboratory at the Riggs School develops integrated diagnostic systems combining microfluidics, molecular biology, and sensor engineering. Collaborations include partnerships with Roche Molecular Diagnostics and global health organizations to deploy field-ready diagnostic tools.
Dr. Amir K. Miri is an Assistant Professor in the Department of Biomedical Engineering at New Jersey Institute of Technology (NJIT) and Director of the Advanced Biofabrication Lab. His work focuses on additive manufacturing for biomedical applications, particularly bioprinting technologies for tissue regeneration and disease modeling. After receiving his PhD in Mechanical Engineering from McGill University (2013) and completing postdoctoral training at the MIT-Harvard Division of Health Sciences and Technology, he began his academic career at Rowan University before joining NJIT. PhD, Mechanical Engineering, McGill University (2013) MSc, Mechanical Engineering, Sharif University of Technology (2007) BSc, Mechanical Engineering, Iran University of Science and Technology (2005) Dr. Miri's research spans advanced bioprinting platforms, including multi-axial extrusion, handheld printers, and digital light projection systems. His work emphasizes the development of biomimetic models for cancer, vocal fold tissue, and vascular systems, with a particular focus on microfluidic integration and material optimization for bioprinting. He has pioneered low-cost prototyping solutions for resource-limited settings and explored the role of extracellular matrix mechanics in cellular behavior. Key trends in his publications include 3D bioprinting for tumor modeling, microfluidic device applications in drug screening, and the use of hydrogels like GelMA in cancer research. His group has also advanced acoustic metasurface technology for biomedical wave manipulation and investigated the interplay between biomaterial rheology and bioprinting resolution. Dr. Miri leads a research team at NJIT focused on biofabrication and microfluidics, though specific student advisees are not listed in the provided information. His lab emphasizes interdisciplinary collaboration, particularly in the development of multi-material and multi-scale tissue constructs.
Tony Jun Huang is the William Bevan Distinguished Professor of Mechanical Engineering and Materials Science at Duke University, with additional professorships in Electrical and Computer Engineering and Biomedical Engineering. His research focuses on acoustofluidics, optofluidics, and micro/nano systems for biomedical diagnostics and therapeutics. Ph.D. in Mechanical and Aerospace Engineering (UCLA, 2005) Huang's research has revolutionized biomedical microsystems through acoustofluidic technologies, enabling contactless particle manipulation, exosome isolation, and advanced diagnostic platforms. His work has been cited over 36,000 times (h-index: 102) with 30 issued/pending patents. Recent publications highlight his innovations in acoustic tweezers, extracellular vesicle analysis, topological acoustofluidics, and AI-assisted biomimetic imaging. His lab develops technologies for single-cell analysis, non-invasive diagnostics, and programmable material systems. 2023 Highly Cited Researcher (Web of Science) 2020 Fellow of the National Academy of Inventors (NAI) 2019 Van C. Mow Medal (ASME) 2017 Analytical Chemistry Young Innovator Award (ACS) 2010 NIH Director's New Innovator Award Huang has taught courses including ME 535: Biomedical Microsystems and mentored numerous graduate students through his Duke Acoustofluidics Lab. His lab's technologies are applied in cancer biomarker detection, Alzheimer's diagnostics, and wound healing hydrogels.
Apl. Prof. Dr. Felix von Stetten is an Associate Professor and Senior Scientist at the Laboratory for MEMS Applications within the Department of Microsystems Engineering (IMTEK) at the University of Freiburg. He also serves as an Executive Board Member at the Hahn-Schickard Institute of Microanalysis Systems. His work bridges academia and industry, focusing on lab-on-a-chip technologies, microfluidics, and energy harvesting for biomedical applications. Education: Studied Agricultural Sciences and Biotechnology at the Technical University of Munich, earned a PhD in Microbiology there. Post-2004, he joined IMTEK’s MEMS Applications Lab, later co-founding Hahn-Schickard’s Lab-on-a-Chip division in 2008, which became an independent institute in 2016 under his leadership. Research Interests: His work centers on miniaturized diagnostic systems (e.g., Lab-on-a-Disk platforms), energy harvesting for medical implants, and microfluidic applications. Key innovations include centrifugal microfluidic systems, smartphone-integrated diagnostic tools, and glucose fuel cell technologies. Publications: Over 1200 citations highlight contributions to microfluidic unit operations, digital PCR, and field-deployable diagnostics. Recent work emphasizes automation in pathogen detection and flexible lab-on-foil platforms. Awards: Not explicitly listed in provided texts. However, his leadership roles and impactful research suggest significant recognition in microsystems engineering. Advising/Grants: Leads major projects like BrainLinks–BrainTools and contributes to initiatives such as FRIAS and PlanOS. Manages interdisciplinary teams and collaborates with industry partners like Endress+Hauser and TwistDx. Labs/Teams: Oversees the Hahn-Schickard Institute for Microanalysis Systems and collaborates with IMTEK’s Application Development group. Active in spin-off ventures such as SpinDiag GmbH.
